CSIMarket


Ideaya Biosciences Inc   (IDYA)
Other Ticker:  
 

Ideaya Biosciences Inc

IDYA's Fundamental analysis








Looking into Ideaya Biosciences Inc growth rates, revenue grew by 230.87 % in III. Quarter 2022 from the same quarter a year ago. Ranking at No. 66

Major Pharmaceutical Preparations industry recorded growth of revenues by 0.81 %

Ideaya Biosciences Inc realized net income compared to net loss a year ago in III. Quarter 2022

More on IDYA's Growth


Ideaya Biosciences Inc
realized net loss in trailing twelve months.

Ideaya Biosciences Inc realized cash outflow of $ -0.16per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 14.82.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.84.


More on IDYA's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 36.03
 Tangible Book Value (Per Share $) 8.97

Ideaya Biosciences Inc
realized net loss in trailing twelve months.

Ideaya Biosciences Inc realized cash outflow of $ -0.16per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 14.82.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.84.

Ideaya Biosciences Inc Price to Book Ratio is at 2 lower than Indusry Avg. of 1266.6. and higher than S&P 500 Avg. of -0.01

More on IDYA's Valuation

  Market Capitalization (Millions $) 739
  Shares Outstanding (Millions) 41
  Employees -
  Revenues (TTM) (Millions $) 50
  Net Income (TTM) (Millions $) -53
  Cash Flow (TTM) (Millions $) -6
  Capital Exp. (TTM) (Millions $) -4
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 36.03
  Tangible Book Value (Per Share $) 8.97

  Market Capitalization (Millions $) 739
  Shares Outstanding (Millions) 41
  Employees -
  Revenues (TTM) (Millions $) 50
  Net Income (TTM) (Millions $) -53
  Cash Flow (TTM) (Millions $) -6
  Capital Exp. (TTM) (Millions $) -4


    IDYA's Profitability Comparisons
Ideaya Biosciences Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2022 to 2.22 %.

Ideaya Biosciences Inc net profit margin of 5.44 % is currently ranking no. 44 in Major Pharmaceutical Preparations industry, ranking no. 135 in Healthcare sector and number 1757 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 12.02
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.11
  Asset Turnover Ratio (TTM) 0.13
  Inventory Turnover Ratio (TTM) -



Ideaya Biosciences Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2022 to 2.22 %.

Ideaya Biosciences Inc net profit margin of 5.44 % is currently ranking no. 44 in Major Pharmaceutical Preparations industry, ranking no. 135 in Healthcare sector and number 1757 in S&P 500.

More on IDYA's Key Ratios



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HRG's Profile

Stock Price

HRG's Financials

Business Description

Fundamentals

Charts & Quotes

HRG's News

Suppliers

HRG's Competitors

Customers & Markets

Economic Indicators

HRG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071